Thus, the availability of a rapid, accessible, and highly accurate method for detecting ApoE4 concentration enables clinicians to efficiently estimate the APOE ε4 status, thereby providing neurologists with relevant information to guide both diagnosis and treatment decisions in patients with suspected or confirmed AD. The gene discussed is APOE; the disease is Alzheimer disease.